Fluid status and its management in Japanese peritoneal dialysis patients

Peritoneal Dialysis International

Volumn 26, Issue 2, 2006, Pages 144-149

  Nakayama, Masaaki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Blood pressure; Combination therapy; Fluid status; Hypervolemia; Japan; Low sodium solution; Overhydration; Salt intake; Tranexamic acid

Indexed keywords

BRADYKININ; GLUCOSE; ICODEXTRIN; PERITONEAL DIALYSIS FLUID; TISSUE PLASMINOGEN ACTIVATOR; TRANEXAMIC ACID;

BODY FLUID; DEATH; DIETARY INTAKE; DRUG MECHANISM; FLUID INTAKE; HEALTH CARE POLICY; HEMODIALYSIS; HUMAN; HYDRATION; HYPERTENSION; HYPERVOLEMIA; JAPAN; KIDNEY FAILURE; MEDICAL EXPERT; PATHOPHYSIOLOGY; PATIENT CARE; PATIENT COMPLIANCE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SODIUM BALANCE; SODIUM INTAKE; SODIUM RESTRICTION; SURVIVAL RATE; TREATMENT WITHDRAWAL; ELECTROLYTE BALANCE; METABOLIC DISORDER;

HUMANS; JAPAN; PERITONEAL DIALYSIS; WATER-ELECTROLYTE BALANCE; WATER-ELECTROLYTE IMBALANCE;

EID: 33747122080     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080602600204     Document Type: Review

References (33)

1. Coles GA. Have we underestimated the importance of fluid balance for the survival of PD patients? Perit Dial Int 1997; 17:321-6.
2. Lameire N, Van Biesen W. Importance of volume and blood pressure control in peritoneal dialysis patients. Perit Dial Int 2001; 21:206-11.
3. Argent NB, Burrell LM, Goodship THJ, Wilkinson R, Baylis PH. Osmoregulation of thirst and vasopressin release in severe chronic renal failure. Kidney Int 1991; 39:295-300.
4. Konings CJ, Kooman JP, Schonck M, Dammers R, Cheriex E, Palmans Meulemans AP, et al. Fluid status, blood pressure, and cardiovascular abnormalities in patients on peritoneal dialysis. Perit Dial Int 2002; 22:477-87.
5. Plum J, Schoenicke G, Kleophas W, Kulas W, Steffens F, Azem A, et al. Comparison of body fluid distribution between chronic hemodialysis and peritoneal dialysis patients as assessed by biophysical and biochemical methods. Nephrol Dial Transplant 2001; 16:2378-85.
6. Koc M, Toprak A, Tezcan H, Bihorac A, Akoglu E, Ozener IC. Uncontrolled hypertension due to volume overload contributes to higher left ventricular mass index in CAPD patients. Nephrol Dial Transplant 2002; 17:1661-6.
7. Cocchi R, Esposti ED, Fabbri A, Lucatello A, Sturani A, Quarello F, et al. Prevalence of hypertension in patients on peritoneal dialysis: results of an Italian multicentre study. Nephrol Dial Transplant 1999; 14:1536-40.
8. Tzamaloukas AH, Saddler MC, Murata GH, Malhotra D, Sena P, Simon D, et al. Symptomatic fluid retention in patients on continuous peritoneal dialysis. J Am Soc Nephrol 1995; 6:198-206.
9. Nakayama M, Kawaguchi Y, for The Water and Electrolyte Balance Study Group in CAPD. Multicenter survey on hydration status and control of blood pressure in Japanese CAPD patients. Perit Dial Int 2002; 22:411-14.
10. Kawaguchi Y, Ishizaki M, Imada Y, Ohira S, Kuriyama S, Nakamoto H, et al. A study of reason of withdrawal from peritoneal dialysis in Japan [in Japanese]. Jin to Touseki (Peritoneal Dialysis 2002) 2002; 53:9-19.
11. USRDS Chapter 6. Outcomes: hospitalization & mortality. In: Excerpts from the United States Renal Data System 2004 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Am J Kidney Dis 2005; 45(Suppl 1):5127.
12. Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure - result for 24 hour urinary sodium and potassium excretion. Br Med J 1988; 297:319-28.
13. Ministry of Health, Labour and Welfare, Japan. Available in Japanese at: http://www.mhlw.go.jp/houdou and available in English at http://www.mhlw. go.jp/english/index.html
14. Institute of Medicine of the National Academies. Available at: http://www.iom.edu
15. Katsuya T, Ogihara T. Essential hypertension and genetic trait. In: Fujita T, ed. Salt and Hypertension [in Japanese]. Tokyo: JMP; 2002: 15-21.
16. Japanese Society of Nephrology. Guideline of Dietary Therapy for Patients with Renal Disease. Tokyo: Tokyo Igakusya; 1998: 88.
17. Japanese Society for Dialysis Therapy. The current state of chronic dialysis treatment in Japan (as of December 31, 2002). Ther Apher Dial 2003; 7:3-35.
18. Davies SJ, Phillips L, Naish PF, Russel GI. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 2001; 12:1046-51.
19. Nomoto Y, Kawaguchi Y, Sakai S, Hirano H, Kubo H, Ohira S. et al. Sclerosing encapsulating peritonitis (SEP) in patients on continuous ambulatory peritoneal dialysis-definition, diagnosis and treatment recommendation, 1997 update [in Japanese]. J Jpn Soc Dial Ther 1998; 31: 303-11.
20. Yanase T, Ikeda K, Hori T, Yoshida H, Takamura H, Tokumoto M, et al. Effect of tranexamic acid on ultrafiltration volume [Abstract; in Japanese]. Nihon Fukumaku Toseki Kenkyukai 1996: 2.
21. Kuriyama S, Nakayama M, Tomonari H, Kawaguchi Y, Hosoya T. Tranexamic acid increases peritoneal ultrafiltration volume in patients on CAPD. Perit Dial Int 1999; 19:38-44.
22. Nakayama M, Kuriyama S, Kato N, Hayakawa H, Ikeda M, Terawaki H, et al. Three CAPD cases who maintained increased ultrafiltration volume by long-term and intermittent oral administration of low dose of tranexamic acid [in Japanese]. J Jpn Soc Dial Ther 2001; 34:1333-7.
23. Yoshimura K, Terawaki H, Seto K, Hasegawa T, Hosoya T. A case of CAPD patient with the change of translymphatic fluid absorption by tranexamic acid administration evaluated by 99mTc-HSAD scintigraphy [in Japanese]. J Jpn Soc Dial Ther 2005; 38:1221-5.
24. Terawaki H, Nakayama M, Seto K, Yoshimura K, Hasegawa T. Measurement of translymphatic fluid absorption using technetium-99m human serum albumin diethylenetriamine pentaacetic acid in continuous ambulatory peritoneal dialysis patients. Ther Apher Dial 2004; 8:305-12.
25. PD+HD Combination Therapy Study Group. Review of combination of peritoneal dialysis and hemodialysis as a modality of treatment for end-stage renal disease. Ther Apher Dial 2004; 8:56-61.
26. Arizona K, Nomura T, Matsuoka K, Fukui H, Miyamoto T, Kukiyama A, et al. Intermittent peritoneal resting as an effective treatment for ultrafiltration failure at the initiation of CAPD [in Japanese]. Jin to Touseki (Peritoneal Dialysis 2000) 2000; 49:122-6.
27. Nolph KD, Hano JE, Teschan PE. Peritoneal sodium transport during hypertonic peritoneal dialysis: physiologic mechanism and clinical implications. Ann Intern Med 1969; 70:931-41.
28. Gault MH, Ferguson EL, Sidhu JS, Corbin RP. Fluid and electrolyte complication of peritoneal dialysis. Ann Intern Med 1971; 75:253.
29. Davies S, Naish PF, Russell GI. Sodium sieving: factors determining the gap between ultrafiltration and sodium removal in PD [Abstract]. Perit Dial Int 2000; 20:116.
30. Nakayama M, Hasegawa T, Kubo H, Yamamoto H, Shigematsu T, Kawaguchi Y, et al. Low Na concentration solution for CAPD. Clin Nephrol 1996; 45:66-8.
31. Nakayama M, Kawaguchi Y, Yokoyama K, Kubo H, Miura Y, Watanabe S, et al. Anti-hypertensive effect of low Na concentration (120 mEq/L) solution for CAPD patients. Clin Nephrol 1994; 41:357-63.
32. Nakayama M, Yokoyama K, Kubo H. The effect of ultra-low sodium dialysate in CAPD. A kinetic and clinical analysis. Clin Nephrol 1996; 45:188-93.
33. Khandelwal M, Oreopoulos DG. Is there a need for low sodium dialysis solution for peritoneal dialysis patients? Adv Perit Dial 2004; 20:156-62.